Clinical Trials News

Text Size

May 2012

Anti-HIV Drug Use During Pregnancy Does Not Affect Infant Size, Birth Weight

April 2012

Possible Clues Found to Why HIV Vaccine Showed Modest Protection

January 2012

NIAID Publishes Findings from Vaccine Research Study in Monkeys

December 2011

HPTN 052 Named 2011 Breakthrough of the Year by Science

November 2011

NIH Discontinues Tenofovir Vaginal Gel in 'VOICE' HIV Prevention Study

'VOICE' HIV Prevention Trial Modified

Scientists Determine How Antibody Recognizes Key Sugars on HIV Surface: NIH-Led Study Advances HIV Vaccine Research

Cholesterol Levels Elevated In Toddlers Taking Anti-HIV Drugs

October 2011

NIH researchers show how anti-HIV drug acts to block herpes virus

HPTN 058 HIV Prevention Study Among Injection Drug Users To Close Early

September 2011

NIH modifies ‘VOICE’ HIV prevention study in women - September 28, 2011

July 2011

CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection among Heterosexuals - July 13, 2011

June 2011

NIH Scientists Reactivate Immune Cells Exhausted by Chronic HIV - June 7, 2011

May 2011

Treating HIV-infected People with Antiretrovirals Protects Partners from Infection - May 12, 2011

Antibodies Help Protect Monkeys from HIV-Like Virus, NIH Scientists Show - May 5, 2011

April 2011

Adaptive Trial Designs Could Accelerate HIV Vaccine Development--NIH Scientists Review Lessons Learned from More than a Decade of Trials - April 20, 2011

The FEM-PrEP HIV Prevention Study and Its Implications for NIAID Research - April 18, 2011

March 2011

NIH Study Examines Best Time for Healthy HIV-infected People to Begin Antiretrovirals - March 7, 2011

November 2010

Landmark Discoveries Characterize NIH HIV/AIDS Research in 2010 - November 29, 2010

Landmark Discoveries Characterize NIH HIV/AIDS Research in 2010 - November 29, 2010

Daily Dose of HIV Drug Reduces Risk of HIV Infection

Daily Dose of HIV Drug Reduces Risk of HIV Infection - November 23, 2010

October 2010

NIH Studies Influence Revision of WHO Guidelines for Treating HIV-Infected Women and Infants - October 13, 2010

July 2010

NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB - July 22, 2010

NIH-Funded Study Finds Early HAART During TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB - July 22, 2010

NIH Scientist Anthony S. Fauci to Address Early HIV Infection and a Novel Target for HIV Vaccine Development - July 20, 2010

HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study - July 19, 2010

Increased Use of Treatment Leads to Reduction in New Diagnoses

Future Directions for NIAID’s HIV Vaccine Clinical Research - July 16, 2010

June 2010

Clinical Trials Search Page Updated – June 8, 2010

January 2010

New Study Examines Best Ways to Prevent Maternal and Infant Health - January 21, 2010

December 2009

New Analysis Shows Survival of Children with HIV in the United States Has Improved Dramatically Since 1990s - December 18, 2009

Major Study Finds Anti-HIV Gel Ineffective Among Women - December 14, 2009

Major Study Finds Anti-HIV Gel Ineffective Among Women - December 14, 2009

NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults -- Trial Complements Current Studies in HIV-Infected Children and Pregnant Women

November 2009

New Findings Suggest Strategy to Help Generate HIV-Neutralizing Antibodies - November 19, 2009

October 2009

NIH Launches 2009 H1N1 Influenza Vaccine Trials in HIV-Infected Children, Youth and Pregnant Women - October 9, 2009

September 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study

Clinical Trial of Antiretroviral-based HIV Prevention Strategies for Women Now Under Way

August 2009

HVTN 505 HIV Vaccine Study Begins Enrolling Volunteers

June 2009

Starting Antiretroviral Therapy Earlier Yields Better Clinical Outcomes : Interim Review Leads to Early End of Clinical Trial in Haiti

May 2009

NIH Multicenter AIDS Cohort Study Commemorates 25 Years of Discovery

February 2009

IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals

Anti-HIV Gel Shows Promise in Large-scale Study in Women

August 2008

Anti-HIV `Drug Cocktails¿ Equally Effective in Patients with or without History of Injection Drug Use

July 2008

NIAID Will Not Move Forward With The Pave 100 HIV Vaccine Trial

February 2008

Phase III Clinical Trial Results show Carregeenan to be Safe but not Effective as a Vaginal Microbicide - February 18, 2008

January 2008

Information on Participating in Clinical Trials Now Available on NIHSeniorHealth.gov

November 2007

On the Release of New Data from the HVTN 502 (STEP) HIV Vaccine Study

September 2007

Immunizations Are Discontinued

July 2007

Treating HIV-Infected Infants Early Helps Them Live Longer

First Genome-Wide Study of Infectious Disease Opens New Avenues for HIV Treatment, Vaccines

June 2007

A Brief Skill-Building Program Can Reduce STD or HIV Risk among Inner-City African American Women

May 2007

NIH Press Release - The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges - May 16, 2007

April 2007

NIH and Institut Pasteur Extend Collaboration Agreement for HIV-1 Diagnostics

March 2007

Clinical Trials Units Selected for Newly Restructured HIV/AIDS Clinical Trials Networks

NIAID Press Release - Clinical Trials Units Selected for Newly Restructured HIV/AIDS Research Networks - March 12, 2007

HIV Treatment May Help Reduce Severity of Mental Impairment in Children with HIV Infection

February 2007

NIAID Press Release-First Large-Scale HIV Vaccine Trial in South Africa Opens-February 8, 2007

OHRP Outreach Pamphlet--June 17, 2005

Understanding Risk, What Do Those Headlines Really Mean?

January 2007

NIH Release--Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive RegimenResponse to Treatment Diminished If Treatment Begins Within Six Months Of Preventive Regimen, January 10, 2007

December 2006

Young African American Adults At High Risk for HIV, STDs Even In Absence of High-Risk Behaviors

November 2006

International HIV/AIDS Trial Finds that Risks of Death, AIDS and Other Major Diseases Increase on Episodic Antiretroviral Therapy

June 2006

NIAID Announces Leadership for Newly Restructured HIV/AIDS Clinical Trials Networks

May 2006

FDA Press Release--Development of Preventive HIV Vaccines for Use in Pediatric Populations--May 5, 2006

January 2006

International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy

Strategies for Management of Anti-Retroviral Therapy (SMART) Trial Q & A's--January 18, 2006

A Large International HIV/AIDS Study Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)

November 2005

NIAID Launches First Phase II Trial of a "Global" HIV/AIDS Vaccine--October 11, 2005

October 2005

NIAID Launches First Phase II Trial of a 'Global' HIV/AIDS Vaccine--October 11, 2005

August 2005

Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research-August 8, 2005

January 2005

NIAID Begins Enrolling Volunteers For Novel HIV Vaccine Study

December 2004

NIAID Seeks Applicants to Lead Revamped HIV/AIDS Clinical Trials Networks

September 2004

B Cells Gone Bad - Researchers Uncover How HIV Causes Abnormalities in Antibody-Producing Cells

July 2004

Thai Study Shows That Inexpensive Treatment Reduces Risk of Mother to Child HIV Transmission

June 2004

Multivitamins During Pregnancy and After Birth Delay Progression of HIV In Women

April 2004

HIV Patients Get Long-Term Boost with Short, Intermittent Drug Regimen

March 2004

Harmless Virus Associated with Longer Life for Some HIV-Positive Men

January 2004

RV144, AN ONGOING HIV VACCINE EFFICACY TRIAL IN THAILAND

Draft Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions (Revision 1)

December 2003

Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients

September 2003

Nevirapine Sustains Advantage Over AZT During Breastfeeding Period

March 2003

Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection (AACTG Protocol A5095)

January 2003

FDA Issues Guidance for Collection of Race and Ethnicity Data in Clinical Trials for FDA Regulated Products

Draft Guidance for Industry and Reviewers on Estimating the Safe Starting Dose in Clinical Trails for Therapeutics in Adult Healthy Volunteers

December 2002

Bush Administration will Seek New Legislation for Mandatory Pediatric Drug Testing

November 2002

New HIV Vaccine Holds Promise of Global Effectiveness

Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection

October 2002

Study Shows Why Some Immune Systems Control HIV

September 2002

Study Sheds Light on Cause of an AIDS Treatment Side Effect

July 2002

Study Offers New Insights Into Overcoming Disparities in Health

Exposure to Hepatitis C Has No Effect on Antiretroviral Treatment Outcomes in HIV Patients

June 2002

Cardiac Differences in Infants Born to HIV-Positive Mothers May Persist -- Effects Based on Child's Infection Status

Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks

May 2002

Black and Hispanic HIV Patients Are Less Likely to Get Experimental Medications

Resources for HIV Vaccine Research and Development

Clinical Research on HIV Vaccines

HIV Selectively Suppresses Anti-HIV Defense Cells

March 2002

Review of HIVNET 012

February 2002

NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed Phase III Trial in Thailand to Determine Efficacy Will Be Supported by NIAID through a Combined NIAID-DoD Program

NIAID'S HIV Vaccine Trials Network (HVTN)

December 2001

New Findings Explain T-cell Loss in HIV Infection

November 2001

New Finding May Help Doctors Prevent HIV Drug Resistance

HIV "Rides" into Cells on Membrane Rafts, NIAID Scientists Determine

High HIV Levels Shut Down Anti-HIV Immune Responses

October 2001

Harmless Virus Prevents HIV Variant From Spreading In Human Tissue Blocks

First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (Trial Begins Just One Year after Laboratories Open)

September 2001

Major AIDS Studies to Increase Minority Enrollment, Answer New Questions

Alcohol Researchers Show "Friendly" Virus Slows HIV Cell Growth

August 2001

NIAID Researchers Identify HIV-Induced Changes in B Cells

July 2001

NICHD Funds New Sites To Follow Disease Progression In HIV-Infected Women

NIAID Pediatric AIDS Clinical Trial Units

May 2001

Study Sheds Light on Role of Gender Differences in the Risk of HIV Infection Among Injection Drug Users: High-risk sexual activity plays key role

April 2001

NIAID's HIV Prevention Trials Network (HPTN)

March 2001

New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys

Study Confirms Gender Differences in Progression from HIV to AIDS: Despite Differences in "Viral Load," Men and Women Develop AIDS at the Same Rate

February 2001

Mother-to-Infant HIV Transmission Rate Less Than 2% in Phase III Perinatal Trial

October 2000

Interleukin-2 May Help Patients With Advanced HIV Disease, New Study Shows

September 2000

Promising HIV Vaccine Strategy Identified in Monkey Studies

NIH STUDY DEMONSTRATES SURPRISING COMPLICATION IN HIV INFECTION

August 2000

B Cells May Help Maintain HIV Infection

July 2000

NIH ANNOUNCES NEW INTERNATIONAL NETWORK TO STUDY HIV PREVENTION STRATEGIES

FAUCI PRESENTS NEW DATA ON STRUCTURED INTERMITTENT THERAPY AT XIIITH WORLD AIDS CONFERENCE IN DURBAN, SOUTH AFRICA

UPDATE ON CLINICAL TRIALS OF INTERLEUKIN-2 (IL-2) AS IMMUNE-BASED THERAPY FOR HIV

May 2000

NIAID Creates Global Network to Advance Development of HIV Vaccines

March 2000

Low Blood Levels of HIV Reduce Risk of Heterosexual Transmission

NIAID Researchers Discover Why Some HIV-Infected People Don't Develop AIDS

February 2000

National Institutes of Health Launches "ClinicalTrials.gov"

NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort and an HIV Protease Inhibitor

November 1999

Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection

NIAID Renews Funding for the Adult AIDS Clinical Trials Group

October 1999

NIAID Study: Rapid Rebound of HIV and Reappearance of HIV Reservoirs in Patients Treated with IL-2 and Combination Antiretroviral Drugs Following Cessation of Therapy

August 1999

Study Finds HIV Breastfeeding Risk Highest in Early Months After Birth

Fusion-competent vaccine: An immunogen that induces a potent, broadly reactive anti-HIV neutralizing response in mice

High HIV RNA Levels Major Risk Factor for Mother-to-Child HIV Transmission

July 1999

Combination HIV Vaccine Induces Diverse Immune Responses

HIVNET 012 Questions and Answers

April 1999

NIAID Renews Funding for Multicenter AIDS Cohort Study

February 1999

NIAID Opens First AIDS Vaccine Trial in Africa

Questions and Answers on the Thailand Phase III Vaccine Study and CDC's Collaboration

New Studies Offer Clues to AIDS Vaccine Design and Safety

January 1999

Reassuring Findings About Infants Exposed to Zidovudine

December 1998

Study Offers Hope for Immune Reconstitution after HIV Infection

November 1998

Different Treatment Strategy May be Required for HIV+ Women Who Have Used Injection Drugs

October 1998

Study Finds Less Intensive Treatments may not Maintain HIV Suppression

September 1998

Study Shows Efavirenz Promising in Treating Pediatric HIV Infection: Leads to Approval of New Drug for Treating HIV-infected Children

NIAID Scientists Discover HIV Disease-Slowing Mutation

July 1998

New Laboratory Findings May Help Explain Immunity to HIV in Thai Female Prostitutes

June 1998

New Study Helps Explain How STD's May Increase Risk of HIV Transmission: STD's Damage Cells That Normally Protect Against Infection

Short Course of AZT Given Late in Pregnancy and During Delivery Contributes to Reducing Mother-to-Child HIV Transmission

New Piece in the HIV Puzzle: Findings May Explain Why Disease Progression Differs Among HIV/AIDS Patients

C-Sections Before Labor and Rupture of Membranes Reduce the Risk of Maternal-Infant HIV Transmission by Half

Study Charts Trends in HIV Infection

Interleukin-12 Helps Control Mycobacterium Avium Infection

February 1998

Short-Course Regimen of AZT Proven Effective in Reducing Perinatal HIV Transmission: Offers Hope for Reducing Mother-to-Child HIV Transmission in Developing World

Statement by Donna E. Shalala, Secretary of Health and Human Services, Regarding Findings of Thailand Study of 'Short Course' AZT.

January 1998

Novel Concepts Put to the Test in Three New AIDS Vaccine Trials

December 1997

Studies Shed New Light on HIV Epidemic in India

September 1997

FDA Proposes Rule on Women in Clinical Trials

Mutant Gene Not Sole Explanation for HIV Non-Progression

June 1997

Phase II Prime-Boost HIV Vaccine Trial (AVEG 202/HIVNET 014) Questions and Answers

New Finding Underscores Importance of Controlling Opportunistic Infections in AIDS Patients

Macs and Actg Studies Advance Understanding and Clinical Use of HIV Prognostic Markers

Study Of Low-dose Oral Alpha Interferon Closes

CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing Countries

May 1997

Limited Course Of Thalidomide Effective In Treating Aids-related Mouth Ulcers

Study Shows That Doxil is Highly Effective and Safe in the Treatment of Advanced Kaposi's Sarcoma

Study Provides Baseline Measurements of Viral Load in Pediatric AIDS

HIV Prevention Efficacy Trials

HIV Vaccine Volunteer Update

April 1997

CD4+ T Cell Diversity, Lost in Late-Stage HIV Disease, Is Not Immediately Restored by Therapy

NIAID Evaluates N-9 Film as Microbicide

March 1997

STATEMENT ON ACTG PROTOCOL 185

IL-2 Injections Safely Boost CD4+ T Cell Levels in HIV-Infected Patients

February 1997

NIAID Funds Pediatric AIDS Clinical Trials Group

Study Confirms that Combination Treatment Using a Protease Inhibitor Can Delay HIV Disease Progression and Death

Pediatric AIDS Clinical Trials Group: Questions and Answers Concerning the Competitive Renewal

CCR5 and Protection Against HIV-1 Infection

Developing Options for Perinatal HIV Prevention in the Developing World: Researchers Worldwide Collaborate to Develop Practical Therapies

Clinical Trials for AIDS Therapies

January 1997

ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function

Summary of the Meeting of a Panel to Review Studies of Transplacental Toxicity of AZT

Background on the Carey Study

Background on the Weller Study

November 1996

New ACTG 076 Analysis Emphasizes Importance of Offering AZT Therapy to All HIV-Infected Pregnant Women

NIAID Statement

October 1996

IL-2 Therapy Doubles CD4+ T Cell Counts in HIV-Infected People

ACTG 175, CPCRA 007 Trial Results Published

September 1996

Interleukin-2 Continues to Show Promise as HIV Therapy

CRCRA Researchers Present OI Studies at Vancouver

Volunteers Sought for HIV Treatment Study

August 1996

Couples Study in Haiti Shows Reduction in Heterosexual HIV Transmission

NIH-Sponsored Study Stopped: New Drug Does Not Control AIDS-Related Eye Disease

July 1996

Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients

IL-2 Therapy: Encouraging Data on Quality of Life Reported for Immune-Boosting Drug

Interleukin-2 Injections Produce Dramatic, Sustained Increases in CD4+ T Cell Counts in Patients with Early-Stage HIV Disease

NIAID Study Rules Out High-Dose Clarithromycin for AIDS-Related MAC

AIDS Vaccine Research Highlights

A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors

NIAID Study Finds Initial Intermittent Treatment Effective for HIV-Related TB

June 1996

Studies Shed New Light on Mother-to-Infant HIV Transmission

May 1996

MACS Study: HIV RNA Levels Predict Clinical Outcome

Immune System Activation Boosts HIV Replication in HIV-Infected People

April 1996

AIDS Virus Reformatted to Shuttle Repair Genes to Diseased Brains

Gene Therapy Prolongs CD4+ T Cell Survival in HIV-Infected Individuals

Vaccines in Clinical Trials

Low-Dose Oral Alpha Interferon Study Opens

March 1996

Genetic Markers May Influence Disease-Free Interval in HIV-Infected People

CPCRA 007: Preliminary Results of Combination Antiretroviral Study

Studies Examine Relationship of Viral Load to Maternal HIV Transmission

ACTG 152: New Insights Into Pediatric Antiretroviral Therapy

February 1996

ACTG PROTOCOL 152: Questions and Answers

ACTG 152: Efficacy and Safety Study Results

January 1996

Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules

Two-Drug Treatment is Effective Against Recurrent Eye Infection in AIDS Patients

November 1995

Adult AIDS Clinical Trials Group: Questions and Answers Concerning the Competitive Renewal.

NIAID HIV/AIDS Vaccine Research and Development Strategy and Opportunity

NIAID Funds Adult AIDS Clinical Trials Group

October 1995

Analyses of Peptide T Efficacy on Neuropsychological Performance in HIV Seropositive Individuals With Cognitive Impairment

Volunteers Needed for Study of HIV Viral Load Test

September 1995

AHCPR-Funded Study Finds Progression of HIV Disease Not Related to Race, Sex, or Drug Use

ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS, Death in Patients with Intermediate-Stage HIV Disease.

Questions and Answers: AIDS Clinical Trials Group (ACTG) 175

August 1995

CPCRA CMV Study CPCRA 023: Questions and Answers.

June 1995

NIAID Launches Three New AIDS Vaccine Trials

April 1995

NIAID Expands Research on Topical Microbicides to Prevent STDs in Women

March 1995

Therapies for AIDS-Related Infections--Two Studies Published

HIV Vaccine Preparedness Study

Questions and Answers about the NIAID Interleukin-2 Study

Interleukin-2 Produces Significant, Sustained Increases in CD4+ T Cells in HIV-Infected People

February 1995

ARAC Reaffirms Need for Low-Dose Oral Alpha Interferon Study

Interim Results Lead to Discontinuation of AZT-Only Study Arm

Progress in HIV Vaccine Development Discussed

Gene Therapy for HIV Infection

January 1995

NIAID Researchers Report New Data on Non-Progressive HIV Infection

What's What in NIAID-Supported HIV Vaccine Research

November 1994

NIAID Trial of Triple Drug Combination for HIV Infection Closes

ACTG 241: Executive Summary

September 1994

NIAID Mobilizes Teams of Scientists to Advance Novel AIDS Therapies

August 1994

HIV Burden Unchecked by Antiretroviral Therapy In Early Stage Disease

July 1994

NIAID Expands HIV Vaccine Clinical Trial Sites

June 1994

NIAID Advisors Recommend Continuing But Not Expanding at This Time Ongoing Trials of Two Candidate HIV Vaccines

Creating an NIH Clinical Trials Registry: A User Friendly Approach to Health Care: The National Institutes of Health (NIH)

HIV Infection in Vaccine Trial Volunteers

May 1994

ACTG 229: Antiviral Trial of Combination Therapy

ACTG 229: Executive Summary

April 1994

Scientific Review Supports Expanded Clinical Studies of two Candidate HIV Vaccines

Effectiveness in Disease and Injury Prevention: Zidovudine for the Prevention of HIV Transmission from Mother to Infant

February 1994

AZT Reduces Rate of Maternal Transmission of HIV

ACTG 076 Questions and Answers

Executive Summary: Abstract ACTG 076. A Phase III Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Zidovudine (ZDV) for the Prevention of Maternal-Fetal Transmission

December 1993

Blood Component Could Help Immune Cells Fight AIDS

Women in Clinical Trials

ACTG Assessment: Organization and Management

October 1993

AIDS Vaccines Contracts Pave Way for Large National and International Studies

NIAID HIV Vaccine Trials Update

AIDSTRIALS and AIDSDRUGS

July 1993

Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections

June 1993

Women's Interagency HIV Study Begins.

ACTG Minority Sites Funded, Pediatric ACTGs Renewed

ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression

Clinical Trials of HIV/AIDS Vaccines IX International Conference on AIDS Highlights

May 1993

AIDS Clinical Trial Tests Acupuncture and Amitriptyline for Pain Relief

NIAID Opens Combination Therapy Trial for HIV Infection

First Clinical Trials of AIDS Vaccine in HIV-Infected Pregnant Women

April 1993

First Large U.S. Study of TB Therapy For HIV-Infected Launched

FDA Plans Policy Change on Women in Clinical Trials

Partial Results of AZT Study Reported in Lancet

Concorde Trial

March 1993

First HIV Vaccine Therapy Trial Begins In HIV-Infected Children

16 Vanguard Centers Selected To Launch Landmark Women's Health Research Studies

NIAID Launches HIV Therapy Trial of Protease Inhibitor

HIV Disease is Active and Progressive in Lymphoid Organs During Clinical Latency, NIAID Researchers Report

NIAID Begins Study of New Drug for HIV Infection

February 1993

Results of Trial of ddI in Patients Intolerant of AZT Announced

NIAID Begins First Test of Novel HIV Peptide Vaccine

Features of CD4+ T Cell Suppression Identified Among People Without HIV Infection

Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy

Clinical Alert: Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy

December 1992

First HIV Vaccines Move Into Phase II Testing In Uninfected Volunteers

November 1992

Multi-Site Trial Begins of the Anti-AIDS Drug, Tat Antagonist

April 1992

Early Use of AZT Reduces Risk of Death

Summary of Preliminary Analysis of Study Comparing ddI and ZDV

January 1992

Study Shows Promise of Fluconazole for Treatment of AIDS-Related Cryptococcal Meningitis

December 1991

ACTG 106: AZT/ddC Combination Shows Benefits for Patients with Advanced HIV Disease

August 1991

Clinical Research on AIDS Vaccines

May 1991

NIAID AIDS RESEARCH: OPPORTUNISTIC INFECTIONS (Part 2): NIAID-Supported Preclinical and Clinical Research